Libri di William C. Koller

The two volumes on Parkinson's disease in the "Handbook of Clinical Neurology" (Series Editors: Michael J. Aminoff, Department of Neurology, University of California, San Francisco, USA; Francois Boller, Bethesda, USA; Dick F. Swaab, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands) cover a group of disorders that constitute the commonest of neurodegenerative diseases and one that is assuming ever greater importance with the aging of the population in developed countries. The coverage reflects the dramatic advances in understanding of the biochemical background of parkinsonism and the resulting developments in the pharmacological management of the disease.These volumes give a comprehensive account of the subject for both clinical neurologists and those researching in the neurosciences. Part I covers the scientific background, general aspects of Parkinson's disease, clinical aspects and etiology. Part II covers the medical and surgical treatment of Parkinson's disease, complications of therapy and the other parkinsonian syndromes.

This volume provides comprehensive information on Parkinson's disease and related disorders, a group of diseases that are among the most common in the field of neurodegenerative study. Through a high-level presentation of new research regarding these diseases, this handbook will give clinicians and neuroscientists alike a better understanding of the dramatic pharmacological advances made in the management of Parkinson's disease, and the profound observations that have altered the medical community's approach to other degenerative disorders of the nervous system. Practitioners, researchers, and medical personnel will gain exciting insights into recent developments that form the basis for new therapeutic strategies and management protocols for the various neurological disorders that present with Parkinsonism. It is a comprehensive resource on new advancements in the field of Parkinson's research and related neurodegenerative diseases. It offers important information on dramatic pharmacological advances in the management of Parkinson's disease. It offers a platform to stimulate new research and better understanding of these common and disabling neurological disorders.